Haralick textural features on T2 -weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer.

To explore the association between magnetic resonance imaging (MRI), including Haralick textural features, and biochemical recurrence following prostate cancer radiotherapy.

In all, 74 patients with peripheral zone localized prostate adenocarcinoma underwent pretreatment 3. 0T MRI before external beam radiotherapy. Median follow-up of 47 months revealed 11 patients with biochemical recurrence. Prostate tumors were segmented on T2 -weighted sequences (T2 -w) and contours were propagated onto the coregistered apparent diffusion coefficient (ADC) images. We extracted 140 image features from normalized T2 -w and ADC images corresponding to first-order (n = 6), gradient-based (n = 4), and second-order Haralick textural features (n = 130). Four geometrical features (tumor diameter, perimeter, area, and volume) were also computed. Correlations between Gleason score and MRI features were assessed. Cox regression analysis and random survival forests (RSF) were performed to assess the association between MRI features and biochemical recurrence.

Three T2 -w and one ADC Haralick textural features were significantly correlated with Gleason score (P < 0.05). Twenty-eight T2 -w Haralick features and all four geometrical features were significantly associated with biochemical recurrence (P < 0.05). The most relevant features were Haralick features T2 -w contrast, T2 -w difference variance, ADC median, along with tumor volume and tumor area (C-index from 0.76 to 0.82; P < 0.05). By combining these most powerful features in an RSF model, the obtained C-index was 0.90.

T2 -w Haralick features appear to be strongly associated with biochemical recurrence following prostate cancer radiotherapy. J. Magn. Reson. Imaging 2016.

Journal of magnetic resonance imaging : JMRI. 2016 Jun 27 [Epub ahead of print]

Khémara Gnep, Auréline Fargeas, Ricardo E Gutiérrez-Carvajal, Frédéric Commandeur, Romain Mathieu, Juan D Ospina, Yan Rolland, Tanguy Rohou, Sébastien Vincendeau, Mathieu Hatt, Oscar Acosta, Renaud de Crevoisier

INSERM, U1099, Rennes, France., INSERM, U1099, Rennes, France., INSERM, U1099, Rennes, France., INSERM, U1099, Rennes, France., INSERM, U1099, Rennes, France., INSERM, U1099, Rennes, France., Department of Radiology, Centre Eugène Marquis, Rennes, France., Department of Radiology, Centre Hospitalier Universitaire Pontchaillou, Rennes, France., Department of Urology, Centre Hospitalier Universitaire Pontchaillou, Rennes, France., LaTIM, INSERM UMR 1101, University of Brest, France., INSERM, U1099, Rennes, France., INSERM, U1099, Rennes, France.

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe